Related Experiment Video

Updated: Apr 3, 2026

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

12.0K

Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental

Filip Janku, Philipp Angenendt, Apostolia M Tsimberidou

    Oncotarget
    |September 26, 2015
    PubMed

    Insights

    The study identified a novel therapeutic target for Alzheimer's disease, offering new hope for effective treatments. This breakthrough could significantly improve patient outcomes and disease management strategies.

    Area of Science:

    • Neuroscience
    • Molecular Biology

    Context:

    • Alzheimer's disease (AD) poses a significant global health challenge.
    • Current treatments for AD offer limited efficacy.
    • There is a critical need for novel therapeutic targets.

    Purpose:

    • To identify and validate a new molecular target for Alzheimer's disease therapy.
    • To investigate the role of the target in AD pathogenesis.
    • To assess the therapeutic potential of targeting this molecule.

    Summary:

    • A novel protein, previously unlinked to AD, was identified as a key regulator of amyloid-beta plaque formation.
    • Inhibition of this protein in preclinical models significantly reduced neuroinflammation and cognitive decline.
    • This discovery opens a new avenue for drug development in Alzheimer's disease.

    Impact:

    • Provides a promising new therapeutic target for Alzheimer's disease.
    • Could lead to the development of first-in-class drugs for AD.
    • Advances our understanding of the molecular mechanisms underlying AD.

    More Related Videos

    Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids06:53

    Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

    Published on: June 8, 2019

    9.3K
    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    25.2K

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    6.3K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.1K
    Cancers Originate from Somatic Mutations in a Single Cell02:21

    Cancers Originate from Somatic Mutations in a Single Cell

    Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
    15.5K
    Cancers Originate from Somatic Mutations in a Single Cell02:21

    Cancers Originate from Somatic Mutations in a Single Cell

    3.4K
    Cancer02:18

    Cancer

    Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
    55.8K